Literature DB >> 26541795

Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.

Niels Bergsland1, Robert Zivadinov2, Michael G Dwyer3, Bianca Weinstock-Guttman4, Ralph Hb Benedict4.   

Abstract

BACKGROUND: Deep gray matter (DGM) atrophy is common in multiple sclerosis (MS), but no studies have investigated surface-based structure changes over time with respect to healthy controls (HCs). Moreover, the relationship between cognition and the spatio-temporal evolution of DGM atrophy is poorly understood.
OBJECTIVES: To explore DGM structural differences between MS and HCs over time in relation to neuropsychological (NP) outcomes.
METHODS: The participants were 44 relapsing-remitting and 20 secondary progressive MS patients and 22 HCs. All were scanned using 3T magnetic resonance imaging (MRI) at baseline and 3-year follow-up. NP examination emphasized consensus standard tests of processing speed and memory. We performed both volumetric and shape analysis of DGM structures and assessed their relationships with cognition.
RESULTS: Compared to HCs, MS patients presented with significantly smaller DGM volumes. For the thalamus and caudate, differences in shape were mostly localized along the lateral ventricles. NP outcomes were related to both volume and shape of the DGM structures. Over 3 years, decreased cognitive processing speed was related to localized atrophy on the anterior and superior surface of the left thalamus.
CONCLUSIONS: These findings highlight the role of atrophy in the anterior nucleus of the thalamus and its relation to cognitive decline in MS.
© The Author(s), 2015.

Entities:  

Keywords:  MRI; Multiple sclerosis; cognitive impairment; imaging; shape analysis; thalamus

Mesh:

Year:  2015        PMID: 26541795     DOI: 10.1177/1352458515616204

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  28 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  White-matter-nulled MPRAGE at 7T reveals thalamic lesions and atrophy of specific thalamic nuclei in multiple sclerosis.

Authors:  Vincent Planche; Jason H Su; Sandy Mournet; Manojkumar Saranathan; Vincent Dousset; May Han; Brian K Rutt; Thomas Tourdias
Journal:  Mult Scler       Date:  2019-02-07       Impact factor: 6.312

Review 3.  Brain MRI atrophy quantification in MS: From methods to clinical application.

Authors:  Maria A Rocca; Marco Battaglini; Ralph H B Benedict; Nicola De Stefano; Jeroen J G Geurts; Roland G Henry; Mark A Horsfield; Mark Jenkinson; Elisabetta Pagani; Massimo Filippi
Journal:  Neurology       Date:  2016-12-16       Impact factor: 9.910

4.  Measurement of Cortical Thickness and Volume of Subcortical Structures in Multiple Sclerosis: Agreement between 2D Spin-Echo and 3D MPRAGE T1-Weighted Images.

Authors:  A Vidal-Jordana; D Pareto; J Sastre-Garriga; C Auger; E Ciampi; X Montalban; A Rovira
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-24       Impact factor: 3.825

5.  Variations in Thalamic Anatomy Affect Targeting in Deep Brain Stimulation for Epilepsy.

Authors:  Chengyuan Wu; Pierre-François D'Haese; Srivatsan Pallavaram; Benoit M Dawant; Peter Konrad; Ashwini D Sharan
Journal:  Stereotact Funct Neurosurg       Date:  2016-11-16       Impact factor: 1.875

6.  Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality.

Authors:  Ferdinand Schweser; Ana Luiza Raffaini Duarte Martins; Jesper Hagemeier; Fuchun Lin; Jannis Hanspach; Bianca Weinstock-Guttman; Simon Hametner; Niels Bergsland; Michael G Dwyer; Robert Zivadinov
Journal:  Neuroimage       Date:  2017-10-31       Impact factor: 6.556

Review 7.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

8.  Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis.

Authors:  Antonia Valentina Genovese; Jesper Hagemeier; Niels Bergsland; Dejan Jakimovski; Michael G Dwyer; Deepa P Ramasamy; Alexis A Lizarraga; David Hojnacki; Channa Kolb; Bianca Weinstock-Guttman; Robert Zivadinov
Journal:  Radiology       Date:  2019-09-24       Impact factor: 11.105

9.  Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.

Authors:  G C Chiang; J Hu; E Morris; Y Wang; S A Gauthier
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

10.  Sleep Disturbance and Cognitive Dysfunction in Multiple Sclerosis: a Systematic Review.

Authors:  Abbey J Hughes; Katherine M Dunn; Trisha Chaffee
Journal:  Curr Neurol Neurosci Rep       Date:  2018-01-29       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.